Solid Biosciences Inc. — Director's Dealing 2022

Dec 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-12-02

Reporting Person: Ganot Ilan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-02	Stock Option (Right to Buy)	$6.77	A	13333	Acquired	2032-12-02	Common Stock (13333)	Direct
2022-12-02	Restricted Stock Units	$	A	6333	Acquired		Common Stock (6333)	Direct

Footnotes

F1: This option (the "Ganot Option") was granted on December 2, 2022 (the "Grant Date") and vests in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Separation Date (as defined in that certain Executive Transition and Separation Agreement between the issuer and Mr. Ganot, the "Ganot Agreement"); provided that in the event of a Change in Control (as defined in the Ganot Agreement) the Ganot Option shall accelerate in full.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "Ganot RSUs").

F3: The Ganot RSUs were granted on the Grant Date and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Separation Date (as defined in the Ganot Agreement); provided that in the event of a Change in Control (as defined in the Ganot Agreement) the Ganot RSUs shall accelerate in full.